Versatile synthesis of head group functionalized phospholipids via oxime bond formation

Organic Letters

Volumn 10, Issue 21, 2008, Pages 4847-4850

  Furuta, Takumi ^a   Mochizuki, Masayoshi ^b   Ito, Mai ^b   Takahashi, Tadanobu ^b   Suzuki, Takashi ^b   Kan, Toshiyuki ^b  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; COPPER; OXIME; PHOSPHOLIPID;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

CHELATING AGENTS; COPPER; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR STRUCTURE; OXIMES; PHOSPHOLIPIDS;

EID: 58149156304     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol8019346     Document Type: Article

References (39)

1. For examples, see: (a) Prestwich, G. D. Acc. Chem. Res. 1996, 29, 503.
2. (b) Regen, S. L. Curr. Opin. Chem. Biol. 2002, 6, 729.
3. Ringsdorf, H.; Schlarb, B.; Venzmer, J. Angew. Chem., Int. Ed. 1988, 27, 113.
4. (a) Grogan, M. J.; Kaizuka, Y.; Conrad, R. M.; Groves, J. T.; Bertozzi, C. R. J. Am. Chem. Soc. 2005, 127, 14383.
5. (b) Rabuka, D.; Forstner, M. B.; Groves, J. T.; Bertozzi, C. R. J. Am. Chem. Soc. 2008, 130, 5947.
6. Frias, J. C.; Williams, K. J.; Fisher, E. A.; Fayad, Z. A. J. Am. Chem. Soc. 2004, 126, 16316.
7. Utku, Y.; Dehaft, E.; Ouerfelli, O.; Piano, F.; Zuckermann, R. N.; Pagano, M.; Kirshenbaum, K. Mol. BioSyst. 2006, 2, 312.
8. (a) Drakopoulou, E.; Tsivgoulis, G. M.; Mukhopadhyay, A.; Brisson, A. Tetrahedron Lett. 2000, 41, 4131.
9. (b) Thompson, D, H.; Zhou, M.; Grey, J.; Kim, H. Chem. Lett. 2007, 36, 956.
10. Matsuoka, S.; Matsumori, N.; Murata, M. Org. Biomol Chem. 2003, 1, 3882.
11. Cavalli, S.; Handgraaf, J.-W.; Tellers, E. E.; Popescu, D. C.; Overhand, M.; Kjaer, K.; Vaiser, V.; Sommerdijk, N. A. J. M.; Rapaport, H.; Kros, A. J. Am. Chem. Soc. 2006, 128, 13959.
12. Wang, P.; Blank, D. H.; Spencer, T. A. J. Org. Chem. 2004, 69, 2693. See also, ref 1a.
13. Furuta, T.; Sakai, M.; Hayashi, H.; Asakawa, T.; Kataoka, F.; Fujii, S.; Suzuki, T.; Suzuki, Y.; Tanaka, K.; Fishkin, N.; Nakanishi, K. Chem. Commun. 2005, 4575.
14. For example, see: Ermacora, M. R.; Ledman, D. W.; Fox, R. O. Nat. Struct. Biol. 1996, 3, 59.
15. Datwyler, S. A.; Meares, C. F. Trends Biochem. Sci. 2000, 25, 408.
16. (a) Jeon, J. W.; Son, S. J.; Yoo, C. E.; Hong, I. S.; Song, J. B.; Sun, J. Org. Lett. 2002, 4, 4155.
17. (b) Chae, P. S.; Kim, M.; Jeung. C.-S.; Lee, S. D.; Park, H.; Lee, S.; Suh, J. J. Am. Chem. Soc. 2005, 127, 2396.
18. (c) Suzuki, A.; Tsumura, K.; Tsuzuki, T.; Matsumura, S.; Toshima, K. Chem. Commun. 2007, 4260.
19. (d) Suh, J.; Yoo, S. H.; Kim, M. G.; Jeong, K.; Ahn, J. Y.; Kim, M.; Chae, P. S.; Lee, T. Y.; Lee, J.; Lee, J.; Jang, Y. A.; Ko, E. H. Angew. Chem., Int. Ed. 2007, 46, 7064.
20. The oxime bond formation (oxime ligation) has been used to conjugate functional groups, such as fluorescent label, to biomolecules. See the following reference and references cited therein: Dirksen, A.; Hackeng, T. M.; Dawson, P. E. Angew. Chem., Int. Ed. 2006, 45, 7581.
21. Fukase, K.; Yoshimura, T.; Kotani, S.; Kusumoto, S. Bull. Chem. Soc. Jpn. 1994, 67, 473.
22. Xu, Y.; Lee, S, A.; Kutateladze, T. G.; Sbrissa, D.; Shisheva, A.; Prestwich, G. D. J. Am. Chem. Soc. 2006, 128, 885.
23. Wey, S.-J.; Augustyniak, M. E.; Cochran, E. D.; Ellis, J, L.; Fang, X.; Garvey, D. S.; Janero, D. R.; Letts, L. G.; Martino, A. M.; Melim, T. L.; Murty, M. G.; Richardson, S. K.; Schroeder, J. D.; Selig, W. M.; Trocha, A. M.; Wexler, R. S.; Young, D. V.; Zemtseva, I. S.; Zifcak, B. M. J. Med. Chem. 2007, 50, 6367.
24. Sun, J.; Oh, S. J. Org. Chem. 2000, 65, 7534.
25. (a) Kumar, C. V.; Buranaprapuk, A. Angew. Chem., Int. Ed. 1997, 36, 2085.
26. (b) Kumar, C. V.; Buranaprapuk, A.; Opiteck, G. J.; Moyer, M. B.; Jockusch, S.; Turro, N. J. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 10361.
27. (c) Kumar, C. V.; Buranaprapuk, A. J. Am. Chem. Soc. 1999, 121, 4262.
28. (d) Buranaprapuk, A.; Kumar, C. V.; Jockusch, S.; Turro, N. J. Tetrahedron 2000, 56, 7019.
29. Zaid, A.; Sun, J.-S.; Nguyen, C.-H.; Bisagni, E.; Garestier, T.; Grierson, D. S.; Zain, R. ChemBioChem 2004, 5, 1550.
30. For details of how the cyclen 6f was prepared, see the Supporting Information.
31. For protein cleavage by the 1,10-phenanthroline-Cu(II) complex, see: (a) Wu, J.; Perrin, D. M.; Sigman, D. S.; Kaback, H. R. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 9186.
32. (b) Galasco, A.; Crouch, R. K.; Knapp, D. R. Biochemistry 2000, 39, 4907. For protein cleavage by the cyclen-Cu(II) complex, see the following references and references cited therein: Jang, S. W.; Suh, J. Org. Lett. 2008, 10, 481.
33. Wilson, I. A.; Skehel, J. J.; Wiley, D. C. Nature 1981, 289, 366.
34. Determined by running SDS-PAGE on the precipitates from 2a, 2c, 2d, and 8f and visualizing bands for HA1 and HA2, both of which correspond to HA. We had difficulty applying the phenantriroline phospholipids 8e to membrane reconstitution due to its insolubility in the 5% octylglucoside solution. See the Supporting Information.
35. Selimova, L. M.; Zaides, V. M.; Zhdanov, V. M. J. Virol. 1982 44, 450.
36. Staining with biotin-ConA also decreased the HA1 band. Cleaved HA fragments were visualized as smears by immunostaining with anti-P50 (H1N2) rabbit polyclonal antibody. See Supporting Information. For anti-P50, see: Suzuki, T.; Takahashi, T.; Guo, C.-T.; Hidari, K. I.-P. J.; Miyamoto, D.; Goto, H.; Kawaoka, Y.; Suzuki, Y. J. Virol. 2005, 79, 11705.
37. 2 and sodium ascorbate. See Supporting Information.
38. For the cleavage of HA with 2c and 2d, see Supporting Information.
39. Pyrene and 2-hydroxynaphthalene themselves did not show cleavage activity. See Supporting Information.